Considerations For Drug Delivery Device and Combination Products

Drug delivery devices and combination products are evolving by the day —more compact and portable, more user-friendly, more robust, and more accessible to varied patient populations than ever before. In this eBook, Med Device Online has collected wisdom from some of the experts in this field among our editorial contributors.

Michael Song, Ph.D., of AstraZeneca pulls double duty in leading off the eBook with two articles, both delving into the vital considerations that must take place before embarking on development of a drug delivery device. Kate Cook of Greenleaf Health unravels confusion twirled around FDA’s 2019 draft guidance Principles of Premarket Pathways for Combination Products. Charles L Mauro of MAURO Usability Science explores usability concerns associated with biopharmaceutical delivery devices, while Natalie Abts of Genentech explores the thought process behind Xcertia’s usability guidelines for mHealth applications.

Thank you for taking the time to read, and please reach out to let us know topics you’d like to see covered in the future!